IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 197 filers reported holding IMPAX LABORATORIES INC in Q2 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,869,000 | – | 61,206 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $37,950,000 | 5.83% |
| Healthcare Value Capital, LLC | 200,000 | $2,530,000 | 4.33% |
| Ratan Capital Management LP | 354,400 | $4,483,000 | 2.15% |
| SECTOR GAMMA AS | 534,311 | $6,759,000 | 1.08% |
| Sivik Global Healthcare LLC | 168,030 | $2,126,000 | 0.99% |
| Schonfeld Strategic Advisors LLC | 547,157 | $6,922,000 | 0.69% |
| Iguana Healthcare Management, LLC | 100,000 | $1,265,000 | 0.63% |
| Century Capital Management, LLC | 250,716 | $3,172,000 | 0.50% |
| Fosun International Ltd | 300,000 | $3,795,000 | 0.47% |
| Atika Capital Management LLC | 39,500 | $499,000 | 0.24% |